REGN - Regeneron Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts22222726
Avg. Estimate4.384.5318.4421.08
Low Estimate3.583.7815.3614.49
High Estimate6.596.2124.1525.52
Year Ago EPS2.924.1716.3218.44
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts20202524
Avg. Estimate1.51B1.58B6.39B7.07B
Low Estimate1.4B1.5B5.9B6.3B
High Estimate1.68B1.71B6.94B7.95B
Year Ago Sales1.32B1.47B5.87B6.39B
Sales Growth (year/est)14.60%7.50%8.80%10.80%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.3.063.173.854.53
EPS Actual2.924.173.995.23
Difference-0.1410.140.7
Surprise %-4.60%31.50%3.60%15.50%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate4.384.5318.4421.08
7 Days Ago4.344.5218.4421.04
30 Days Ago4.334.5218.4621.08
60 Days Ago4.314.4818.2820.94
90 Days Ago3.934.2617.2920.25
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days4335
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/AN/AN/A
Growth EstimatesREGNIndustrySectorS&P 500
Current Qtr.50.00%N/AN/A0.42
Next Qtr.8.60%N/AN/A0.39
Current Year13.00%N/AN/A0.20
Next Year14.30%N/AN/A0.10
Next 5 Years (per annum)10.79%N/AN/A0.12
Past 5 Years (per annum)34.61%N/AN/AN/A